Viewing Study NCT00735150



Ignite Creation Date: 2024-05-05 @ 7:47 PM
Last Modification Date: 2024-10-26 @ 9:53 AM
Study NCT ID: NCT00735150
Status: COMPLETED
Last Update Posted: 2010-10-11
First Post: 2008-08-12

Brief Title: Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited BreastOvarian Cancer Risk
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Study Overview

Official Title: Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited BreastOvarian Cancer Risk
Status: COMPLETED
Status Verified Date: 2010-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: We are inviting you to participate in a study of how people who have had genetic counseling for breastovarian cancer risk feel about certain reproductive technologies preimplantation genetic diagnosis PGD and prenatal genetic diagnosis PND that may reduce the chances of passing increased risk onto ones children We would also like feedback from patients who have been to our clinic in the past on the best ways to talk about PGD and PND during genetic counseling sessions We are seeking both the opinions of people who are interested in these technologies and those who are not It does not matter whether you have heard of PGD or PND before - you can still participate Your past experience with genetic counseling is valuable to us in deciding how to communicate this information during sessions
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None